Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Več na: https://www.wired.com/story/fda-approves-eli-lillys-glp-1-pill/
nazaj
